EUVIMEDEUVIMED entdecken
Open Access

[Retracted] Combined application of Embelin and tumor necrosis factor‑related apoptosis‑inducing ligand inhibits proliferation and invasion in osteosarcoma cells via caspase‑induced apoptosis

Hao Qian, Yao Chen, Tao Huang, Tiemin Liu, Xiucheng Li, Guangjian Jiang, Wei Zhang, Shuo Cheng, Pengcheng Li

Oncology Letters · 08.06.2026 · 32 (2) · 1-1

DOI: 10.3892/ol.2026.15687 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Letters, online erschienen am 08.06.2026. Verfasst von Hao Qian und 8 weiteren Autor:innen. Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Qian, H., Chen, Y., Huang, T., Liu, T., Li, X., Jiang, G., Zhang, W., Cheng, S., & Li, P. (2026). [Retracted] Combined application of Embelin and tumor necrosis factor‑related apoptosis‑inducing ligand inhibits proliferation and invasion in osteosarcoma cells via caspase‑induced apoptosis. Oncology Letters, 32(2), 1-1. https://doi.org/10.3892/ol.2026.15687

Vancouver

Qian H, Chen Y, Huang T, Liu T, Li X, Jiang G, et al. [Retracted] Combined application of Embelin and tumor necrosis factor‑related apoptosis‑inducing ligand inhibits proliferation and invasion in osteosarcoma cells via caspase‑induced apoptosis. Oncology Letters. 2026;32(2):1-1. doi:10.3892/ol.2026.15687

BibTeX
@article{Qian2026,
  author = {Qian, Hao and Chen, Yao and Huang, Tao and Liu, Tiemin and Li, Xiucheng and Jiang, Guangjian and Zhang, Wei and Cheng, Shuo and Li, Pengcheng},
  title = {[Retracted] Combined application of Embelin and tumor necrosis factor‑related apoptosis‑inducing ligand inhibits proliferation and invasion in osteosarcoma cells via caspase‑induced apoptosis},
  journal = {Oncology Letters},
  year = {2026},
  volume = {32},
  number = {2},
  pages = {1--1},
  doi = {10.3892/ol.2026.15687}
}
Kostenlos starten →